Clinical Trial Update: Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of the combination of sintilimab and apatinib with chemotherapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Apatinib (apatinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Jiuda Zhao | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN